Archives
-
EdU Imaging Kits (488) for NSCLC Proliferation
2026-09-09
Translate S-phase DNA synthesis into a clean, image-ready proliferation readout for cancer, cell-cycle, and pharmacology studies. EdU Imaging Kits (488) combine denaturation-free click chemistry with fluorescence microscopy or flow cytometry, helping preserve morphology and antigen accessibility.
-
WRN Loss, p53/PUMA, and MSI Colorectal Cancer
2026-09-09
This PNAS study explains how WRN helicase loss selectively kills mismatch repair-deficient, microsatellite-instable colorectal cancer cells through a p53/PUMA apoptotic program. Its genetic rescue experiments and xenograft data connect synthetic lethality to a defined tumor-suppressor pathway while identifying p53 status as an important determinant of response.
-
U0126-EtOH: MEK1/2 Inhibitor Workflow
2026-09-08
U0126-EtOH provides a practical way to test whether MEK1/2-dependent ERK signaling drives neuronal stress responses, inflammatory phenotypes, or regenerative patterning. This workflow combines dose discipline, phospho-ERK validation, and spatially informed assay design for more interpretable results.
-
ML216 BLM Helicase Inhibitor: Research Workflows
2026-09-08
ML216 supports a target-focused workflow spanning biochemical helicase assays, BLM-dependent cell proliferation studies, sister chromatid exchange, and translational tumor models. Its value is strongest when paired with genetic controls and when the BLM-focused product data are carefully distinguished from WRN-centered findings in MSI colorectal cancer.
-
TopBP1 Inhibition, PARP Synergy, and Resistance
2026-09-07
Lin et al. developed CS18, a structurally distinct small molecule that selectively targets the TopBP1 BRCT7/8 interface without directly disrupting DNA replication. The study connects TopBP1 complex disruption with MYC suppression, E2F1-dependent apoptosis, PARP inhibitor sensitization, and reversal of osimertinib resistance in EGFR-mutated lung cancer models.
-
T-5224 Workflows for AP-1 Inflammation Studies
2026-09-07
T-5224 provides a selective way to test whether c-Fos/c-Jun AP-1 signaling drives inflammatory, matrix-remodeling, or osteoclastogenic phenotypes. This workflow connects arthritis-focused assays with a carefully bounded extension into infection-associated cancer biology, while emphasizing controls, dose handling, and interpretation.
-
Streptavidin – Cy5 for USP42 Assays
2026-09-05
Streptavidin – Cy5 converts biotinylated antibodies, probes, and proteins into a sensitive far-red readout for imaging and flow cytometry. This guide connects USP42–JNK/p38 breast cancer research with practical assay design, control selection, and troubleshooting for reproducible biotin detection.
-
Disulfiram Workflows for Proteasome and CRC Research
2026-09-04
Disulfiram supports two complementary research paths: copper-sensitive proteasome assays and ALDH2-focused synthetic-lethality studies in APC-deficient colorectal cancer. This practical guide connects reagent handling, cell-based readouts, pathway validation, and troubleshooting for reproducible cancer research.
-
JSH-23 for NF-κB Signaling Experiments
2026-09-04
JSH-23 is an NF-κB inhibitor designed to separate p65 nuclear transcriptional activity from upstream IκB degradation. Its value spans macrophage inflammation assays, pathway-dissection studies, and carefully qualified translational models such as cisplatin-induced acute kidney injury.
-
SNORA38B Rewires NSCLC Immunotherapy Response
2026-09-03
The reference study identifies SNORA38B as an oncogenic small nucleolar RNA that links tumor-cell signaling to an immunosuppressive microenvironment in non-small cell lung cancer. Its evidence supports a mechanistic SNORA38B–E2F1–GAB2/AKT/mTOR axis and shows that SNORA38B inhibition can improve the response to immune checkpoint blockade in preclinical models.
-
TAK-242 (Resatorvid) in Neuroinflammation Workflows
2026-09-03
TAK-242 (Resatorvid) provides a direct pharmacological probe for testing whether TLR4 drives LPS-responsive inflammation, oxidative stress, and microglial activation. This workflow-focused guide connects concentration screening with the aged-rat perioperative neurocognitive disorder model and highlights controls that distinguish pathway-specific effects from toxicity or experimental variability.
-
Cy7 NHS Ester: Practical Labeling Protocol
2026-09-02
Cy7 NHS ester is a water-soluble amino group labeling reagent for preparing near-infrared fluorescent conjugates of proteins, peptides, and related biomolecules. It is suited to aqueous labeling and near-infrared dye for bioimaging workflows, but the conjugate, live-cell compatibility, tissue performance, and quantitative imaging behavior must be validated for each application.
-
MK-1775: Wee1 Kinase Inhibitor Assay Guide
2026-09-02
This scenario-driven guide explains how MK-1775 (Wee1 kinase inhibitor), SKU A5755, can improve interpretation of viability, proliferation, and DNA-damage response assays. It connects Wee1 biology with practical dosing, solvent control, orthogonal readouts, and evidence-based vendor selection.
-
Nile Red Workflows for Lipid Imaging
2026-09-01
Nile Red, or Nile blue oxazone, gives researchers a practical two-channel strategy for distinguishing lipid droplets from broader membrane-associated fluorescence. This guide connects reproducible staining and imaging workflows with lipid metabolism research, including translational assay design inspired by a recent laryngeal cancer biomarker study.
-
Resiquimod (R-848) for Ablation Immunology
2026-09-01
Resiquimod (R-848) converts TLR7/8 biology into a practical tool for studying post-ablation immune activation. Combined with the MR@CaP@HA hydrogel concept, it supports experiments that measure thermal protection, stimulus-responsive release, dendritic-cell maturation, and macrophage reprogramming in one workflow.